Targeting the nitric oxide/cGMP signaling pathway to treat chronic pain
Ya‐Qun Zhou(Tongji Hospital), Dai-Qiang Liu(Tongji Hospital), Long-Qing Zhang(Tongji Hospital), Shao‐Jie Gao(Tongji Hospital), Fan‐He Song(Tongji Hospital), Danyang Li(Qilu Hospital of Shandong University), Jia Sun(Union Hospital), Jiayi Wu(Tongji Hospital)
Cited by 53
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia
|Clinical Infectious Diseases|2020|138
PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
|Current Pharmaceutical Design|2017|126